Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Two Apixaban 5 mg Tablet Formulations in Healthy Thai Adults Under Fasting
TCTR20230109005Phase 1Completed
- Sponsor
- T.O. Chemicals
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of apixaban in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by T.O. Chemicals. Started Mar 2023; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20230109005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230109005.